机构:[1]School of Biomedical Engineering, Hainan University, Haikou, 570228, China[2]Department of Neurobiology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China内科系统老年医学科首都医科大学宣武医院[3]State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences.University of Chinese Academy of Sciences, Shanghai, 200031, China[4]Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou, 510005, China[5]Wincon TheraCells Biotechnologies Co, LTD, Nanning, 530000, China[6]Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai, 200080, China[7]National Clinical Research Center for Ophthalmic Diseases, Shanghai, 200080, China[8]Department of Biological Sciences, School of Science, Xi’an Jiaotong-Liverpool University, Suzhou, 215000, China[9]CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China[10]Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, 100101, China
National Key Basic Research and Development Program
of China (2018YFA0108500, 2019YFA0801402, 2018YFA0800100, 2018YFA0108000, 2018YFA0107200,
2017YFA0102700), "Strategic Priority Research Program" of the Chinese Academy of Sciences, Grant
No. (XDA16020501, XDA16020404), National Natural Science Foundation of China (81671224, 31472056,
31630043), and the Research Start-up Fund of Hainan University (RZ2100003016, RZ2000009939).
第一作者机构:[1]School of Biomedical Engineering, Hainan University, Haikou, 570228, China[2]Department of Neurobiology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China
共同第一作者:
通讯作者:
通讯机构:[1]School of Biomedical Engineering, Hainan University, Haikou, 570228, China[2]Department of Neurobiology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China[3]State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences.University of Chinese Academy of Sciences, Shanghai, 200031, China[4]Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou, 510005, China[8]Department of Biological Sciences, School of Science, Xi’an Jiaotong-Liverpool University, Suzhou, 215000, China[9]CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China[10]Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, 100101, China
推荐引用方式(GB/T 7714):
Yue Feng,Feng Su,Lu Chunling,et al.Synthetic amyloid-β oligomers drive early pathological progression of Alzheimer's disease in nonhuman primates.[J].ISCIENCE.2021,24(9):doi:10.1016/j.isci.2021.103207.
APA:
Yue Feng,Feng Su,Lu Chunling,Zhang Ting,Tao Guoxian...&Jing Naihe.(2021).Synthetic amyloid-β oligomers drive early pathological progression of Alzheimer's disease in nonhuman primates..ISCIENCE,24,(9)
MLA:
Yue Feng,et al."Synthetic amyloid-β oligomers drive early pathological progression of Alzheimer's disease in nonhuman primates.".ISCIENCE 24..9(2021)